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Abstract
Protoporphyrin IX-triplet state lifetime
technique (PpIX-TSLT) is a method
used to measure oxygen (PO2) in human
cells. The aim of this study was to assess
the technical feasibility and safety of
measuring oxygen-dependent delayed
fluorescence of 5-aminolevulinic acid
(ALA)-induced PpIX during upper gas-
trointestinal (GI) endoscopy. Endoscopic
delayed fluorescence measurements
were performed 4 hours after oral
administration of ALA in healthy volunteers. The ALA dose administered was 0, 1,
5 or 20 mg/kg. Measurements were performed at three mucosal spots in the gastric
antrum, duodenal bulb and descending duodenum with the catheter above the mucosa
and while applying pressure to induce local ischemia and monitor mitochondrial respi-
ration. During two endoscopies, measurements were performed both before and after
intravenous administration of butylscopolamine. Delayed fluorescence measurements
were successfully performed during all 10 upper GI endoscopies. ALA dose of 5 mg/kg
showed adequate signal-to-noise ratio (SNR) values >20 without side effects. All pres-
sure measurements showed significant prolongation of delayed fluorescence lifetime
compared to measurements performed without pressure (P < .001). Measurements
before and after administration of butylscopolamine did not differ significantly in the
duodenal bulb and descending duodenum. Measurements of oxygen-dependent del-
ayed fluorescence of ALA-induced PpIX in the GI tract during upper GI endoscopy
are technically feasible and safe.
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1 | INTRODUCTION
Protoporphyrin IX (PpIX) is an endogenous compound syn-
thesized in active mitochondria which can be induced by
administration of its precursor 5-aminolevulinic acid (ALA).
PpIX exhibits oxygen-dependent delayed fluorescence after
photoexcitation [1]. The fluorescence lifetime depends
directly on oxygen concentration, since oxygen acts as a
quencher of excited PpIX molecules. In other words, upon
collision of oxygen with an excited PpIX molecule energy
transfer to oxygen will relax PpIX to the ground state with-
out emission of a photon. More oxygen leads to more colli-
sions and quenching, thereby shortening the delayed
fluorescence lifetime. This phenomenon is described quanti-
tatively by the Stern-Volmer relationship [2], relating the
lifetime to the amount of oxygen (eg, oxygen concentration
or oxygen tension [PO2] ). A detailed description of the prin-
ciples of the PpIX-triplet state lifetime technique (PpIX-
TSLT) can be found in the article written by Harms et al [3].
Introduction of the Cellular Oxygen METabolism (COMET)
monitor (Photonics Healthcare BV, Utrecht, The Netherlands)
made PpIX-TSLT clinically available for measurements on
the skin [4]. The main goal of this study was to investigate
the technical feasibility of delayed fluorescence measurements
in the gastrointestinal (GI) tract during endoscopy.
PO2 measurements in cells of the GI tract during endos-
copy could be of great value, for example, for the diagnostic
work-up of patients suspected to be suffering from chronic
mesenteric ischemia (CMI). CMI is the result of insufficient
blood supply to the GI tract caused by obstruction of mesen-
teric arteries and/or veins [5]. CMI is in >90% caused by
atherosclerosis of minimally one mesenteric artery. Typical
symptoms of CMI are postprandial abdominal pain and
weight loss, however, more atypical symptoms as nausea,
constant abdominal discomfort, vomiting, diarrhea or consti-
pation are also reported [5]. Symptoms alone are of limited
value for the diagnosis of CMI [6]. Mesenteric artery steno-
sis can be detected by CT-angiography, however, the pres-
ence of mesenteric artery stenosis will not necessarily result
in symptomatic disease (CMI) due to an abundant collateral
mesenteric network. The prevalence of mesenteric artery
stenosis in the asymptomatic general population is high (3%-
29%), increasing with age [7, 8]. CMI occurs when extensive
mesenteric artery stenosis and/or an insufficient collateral
network is present. Therefore, a functional test detecting GI
ischemia is highly desired. Currently, visible light
spectroscopy (VLS) and tonometry are used as functional
tests for the diagnostic work-up of patients suspected to be
suffering from CMI.
VLS measures the mucosal capillary hemoglobin oxygen
saturation during upper GI endoscopy [9, 10] and is less
invasive than tonometry measuring luminal pCO2 with a
nasogastric and nasojejunal catheter connected to a cap-
nography [10, 11]. However, the sensitivity of VLS for CMI
is 90% and the specificity is 60% [12], indicating the need to
improve the accuracy of the diagnostic workup. Since in the
original reports of PpIX-TSLT the lifetimes were shown to
be related to mitochondrial oxygen levels [1, 13] this tech-
nique shows promise for diagnosing CMI. The COMET
monitoring device was designed for cutaneous measure-
ments and has been adapted for endoscopic delayed fluores-
cence lifetime measurements. Therefore, the primary aim of
this study was to assess the technical feasibility of delayed
fluorescence measurements of the GI tract during upper GI
endoscopy. Secondary aims were: (a) to determine the dose
of 5-aminolevulinic acid (ALA) needed for endoscopic mea-
surements; (b) to determine the specific measurements loca-
tions; (c) to demonstrate oxygen-dependent signal and,
(d) to determine the influence of butylscopolamine on the
measurements.
2 | METHODS
2.1 | Study design and setting
This work describes a single center study in healthy vol-
unteers. The institutional review board of the Erasmus
MC University Medical Center approved this study
(NL59177.078.16, NL63050.078.17). The study complies
with the Helsinki declaration on research ethics.
2.2 | Participants
Healthy volunteers were recruited by distributing informa-
tion leaflets. Before inclusion the medical history and exis-
tence of GI complaints were evaluated. Blood samples were
taken to detect impaired renal function, and liver test abnor-
malities, defined as estimated glomerular filtration rate
(eGFR) <90 mL/min/m3 or liver test abnormalities >1.5
times upper limit of normal. Healthy volunteers were eligi-
ble if they were able to give written informed consent, had
an unremarkable medical history, and had no GI complaints.
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Volunteers were excluded in case of pregnancy, acute or
chronic porphyria, and a known ALA or porphyrin
hypersensitivity.
2.3 | Study procedures and setup
The healthy volunteers were fasted for at least 6 hours and
ALA (Gliolan, Medac GmbH, Wedel, Germany) was admin-
istered orally 4 hours before the upper GI endoscopy. The
volunteers were discharged after the endoscopy. They were
instructed to report any side effects. Furthermore, they were
instructed to avoid exposure to sunlight as much as possible,
and take precautions (eg, sunglasses, long sleeves) during
the first 24 hours after administration of ALA, since photo-
toxicity after sunlight exposure is a known side effect of
ALA. Adverse events were collected during 7 days.
A probe that could be passed safely through the acces-
sory channel of the endoscope was used for endoscopic
detection of fluorescence light (designed by TNO, produced
and CE-marked by LightGuideOptics, Mechenheim, Ger-
many). The diameter of the accessory channel of the endo-
scope is 3.2 to 4.2 mm and therefore the tip of the probe is
slightly smaller than 3.2 mm. The probe is a fiber optic
assembly with one excitation fiber in the middle directly sur-
rounded by seven detection fibers. The used detection fibers
all have a diameter of 365 μm, and the excitation fiber is
470 μm in diameter. The fibers have a numerical aperture
(NA) of 0.22 ± 0.2. The tips of the fibers are fixed together
in a ferrule. The position of the fiber tips within the ferrule
and distance compared to each other is fixed and does not
change when pressure is applied on the mucosa with the
probe tip or while passing the probe tip through the acces-
sory channel of the endoscope. The excitation fiber of the
probe was connected to the light source in the COMET, a
pulsed 515 nm laser. The detection fiber was connected to
the photomultiplier detection system of the COMET. To pro-
tect the highly sensitive detection system from indirect laser
light a long pass filter (575 nm with OD 4, Edmund Optics,
Barrington, New Jersey) was introduced in the optical path
of the detection branch. During endoscopy, peripheral satu-
ration was continuously monitored and oxygen was adminis-
tered intranasally to maintain a saturation level ≥ 95% (see
Figure 1 for the setup).
Delayed fluorescence lifetime measurements were per-
formed similar to VLS measurements at three anatomical
locations in the descending duodenum, duodenal bulb and
antrum of the stomach [12]. The fiber was positioned
approximately 1 to 5 mm above the mucosa of the target
area. A perpendicular angle of the fiber tip and the target
area is optimal for the signal quality, however, this is not an
important parameter for the outcome of the lifetime measure-
ments. To minimize interference by background noise the
light of the endoscope was switched off during the measure-
ments. Raw delayed fluorescent traces were stored with an
external computer connected through the serial (rs-232) port.
A python script written to store the raw data in a comma-
separated file was used to read the serial buffer. The raw
data were analyzed with software written in LabVIEW (ver-
sion 13.0, National Instruments, Austin, Texas). Lifetimes
were calculated using a rectangular distribution fit, taking
into account the heterogeneity in lifetimes underlying the
measured delayed fluorescence signal [13] unless stated oth-
erwise. The mitochondrial oxygen tension (mitoPO2) read-
ing by COMET was not used since COMET is developed
and tested for measurement on skin and links the measured
lifetimes to the calibration constants for skin cells. Because
this is the first report on delayed fluorescence measurements
through an endoscope, we judged to exercise some restraint
in reporting absolute values of PO2. Therefore, all delayed
fluorescence measurements are represented as reciprocal
lifetimes 1=τ (with τ in microseconds) to obtain a positive
association between oxygen and lifetime. According to the
Stern-Volmer relationship the reciprocal lifetime is linearly
related to the actual PO2. Based on our current understand-
ing of the technology, PO2 measurements with a reciprocal
lifetime >0.1 μs−1 should be considered as non-
physiological in humans with a normal arterial oxygen ten-
sion [1].
2.4 | Determination necessary ALA dose
The appropriate dose of ALA was determined by performing
delayed fluorescence lifetime measurements with different
doses of ALA. Since PpIX is endogenously present and
accumulates in metabolic active cells, such as mucosal cells,
measurements were performed during one upper GI endos-
copy without administration of ALA. In neurosurgery,
20 mg/kg ALA is used to induce enough PpIX to visually
determine the tumor fluorescence under blue light [14]. This
was expected to be an abundant dose for detection of del-
ayed fluorescence in the duodenal region because of the high
cellular turnover and metabolic rate compared to neurological
tissue. Therefore, five upper GI endoscopies were performed
using a dose of 20 mg/kg, two upper GI endoscopies were
performed after administration of 1 mg/kg ALA and two
using a dose of 5 mg/kg. Optimal dosage was based on signal
quality and adverse events. Quality is expressed as signal-to-
noise ratio (SNR). A SNR >20 is considered adequate [4].
2.5 | Determining measurement locations and
demonstrating oxygen-dependent signal
Measurements were obtained at each anatomical location
with the probe hovering 1 to 5 mm above the mucosal
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surface. In order to confirm that the measured delayed fluo-
rescence lifetimes depend on the oxygen concentration, mea-
surements were performed while inducing local mucosal
ischemia. Temporary ischemia was achieved by applying
pressure to the mucosa with the probe. The oxygen supply
to the tissue under the probe is compromised by compres-
sion of the capillaries. Because the oxygen is used within the
cells, and the supply compromised, a prolongation of life-
time was expected due to the decrease in PO2 during appli-
cation of pressure. After minimally 2 seconds of pressure,
three consecutive measurements were taken while pressure
was applied. This process was repeated at two more sites
within each anatomical location. In the situation without
pressure, the tip of the probe was positioned under view in
close proximity of the tissue or just on the tissue without vis-
ible deformation of the mucosa. While providing pressure
the probe is pushed on the tissue and caused tissue deforma-
tion similar to the procedure performed when obtaining tis-
sue biopsies for diagnostic purposes. The exact amount of
pressure applied was not controlled or measured. Measure-
ments started in the descending duodenum and
subsequently, measurements with and without applying
pressure were performed in the duodenal bulb and gastric
antrum.
An oxygen consumption curve was made in two volun-
teers who received 5 mg/kg ALA by taking repeated mea-
surements with an interval of 1 second. Measurements were
performed without applying pressure for minimally
5 seconds; the next 20 seconds measurements were per-
formed while applying pressure to visualize mitochondrial
respiration [15]. SNR and reciprocal lifetime were used to
determine appropriate locations for measurements.
It is known that local oxygen tension will be heteroge-
neously distributed within the tissue [16]. Further analysis
was done on the raw fluorescent traces to determine the
effect of local applied pressure on the reciprocal lifetime and
its distribution, caused by, for example, oxygen heterogene-
ity. By assuming the PpIX to be homogenous distributed
among the GI tract the underlying lifetime distribution can
be obtained with a method described by Golub et al [17].
The trace can be described by a sum of rectangular distribu-
tions and the fractional contribution per reciprocal lifetime
can be recovered. This method was successfully used by our
FIGURE 1 The setup for upper
gastrointestinal (GI) endoscopic
delayed fluorescence measurements: A,
Schematic setup, B, Probe in the
descending duodenum during upper GI
endoscopy, and C, Probe in the
descending duodenum during
endoscopic measurement (endoscopic
light is switched off)
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group to recover oxygen distribution histograms [16, 18, 19]
and is used on specific traces in this study to determine the
distribution of (reciprocal) lifetimes in the signal as a mea-
sure of heterogeneity in the tissue. The fractional distribution
within a trace describes the heterogeneity on a microvascular
and cellular scale. To investigate the heterogeneity on a
larger tissue scale all data recorded above the tissue is com-
bined in a histogram and the individual contributions are
visualized by color.
2.6 | Determining influence of
butylscopolamine
Intravenous administration of butylscopolamine is com-
monly used during upper GI endoscopy to reduce intestinal
contractions. Since butylscopolamine is known to induce
tachycardia causing increased cardiac output, GI tract tissue
oxygen levels could be influenced. This possible influence
was evaluated in two volunteers receiving 5 mg/kg ALA.
All measurements mentioned before were performed in the
descending duodenum, duodenal bulb and gastric antrum.
After intravenous administration of 20 mg but-
ylscopolamine, the measurements were repeated in exactly
the same manner.
2.7 | Statistical analyses
The SNR and reciprocal lifetime were not normally distrib-
uted and therefore described as medians and interquartile
ranges (IQR). Differences in reciprocal lifetimes with and without
pressure and before and after administration of butylscopolamine
were determined using the Wilcoxon-Mann-Whitney test. A
two-tailed P-value of <.05 was considered significant. Sta-
tistical analysis was performed using R (version 3.4.2) [20].
3 | RESULTS
3.1 | Participants
Ten upper GI endoscopies were performed in six healthy vol-
unteers. Nine out of 10 upper GI endoscopies were performed
in females, with a median age of 30 years (IQR
28.5-34.0 years). All endoscopies were performed in non-
smokers and all healthy volunteers gave informed consent. No
oxygen or sedatives were administered during endoscopy. Del-
ayed fluorescence lifetime measurements were successfully
performed during all 10 endoscopies.
3.2 | Determining necessary ALA dose
The SNR for each specific location and dose of ALA are
presented in Table 1 and Figure 2. The endogenous amount
of PpIX showed to be insufficient to measure delayed fluo-
rescence, since SNR was below 20 at all locations. The dose
of 1 mg/kg ALA also showed to be insufficient with SNR
values of the first quartile reaching maximal 18 in the des-
cending duodenum and a median SNR of 29 just above the
lower limit of 20.
SNR in duodenal bulb and descending duodenum were
adequate in the 5 and 20 mg/kg group, however, phototoxic
side effects occurred in three out of five volunteers in the
20 mg/kg group (Table 1). The phototoxicity was observed
on the skin of the face exposed to sunlight after the experi-
ment in all three volunteers with phototoxicity and looked
similar to a sunburned like reaction. Side effects resolved
within 24 hours in all volunteers. Phototoxicity was not
observed in the GI tract and volunteers did not experience
abdominal complaints.
It was concluded that 5 mg/kg was the best dose with suf-
ficient SNR values and without reported side effects. This
dose leaves a margin for suboptimal circumstances, for
example, less conversion of PpIX in patients and losses in
the detection system due to the use of adaptors needed to
couple the measuring probe to the COMET system.
3.3 | Determining measurement locations
The SNR at the gastric antrum location was low compared
to the SNR of the duodenal bulb and descending duodenum.
Only in the 20 mg/kg group, the upper quartile of the values
reached an SNR >20 in the gastric antrum, therefore, the
signal quality in the gastric antrum showed insufficient for
reliable measurements. The lifetime calculation became
more inaccurate if the SNR dropped below 20, resulting in a
scatter of lifetimes with a tendency to non-physiological life-
times, see Figure 3. Since the SNR values in the gastric
TABLE 1 Signal-to-noise ratio (SNR) for measurements with probe position 1 to 5 mm above tissue, data presented as median [interquartile
range], total of 10 upper gastrointestinal endoscopies
Dose 0 mg/kg 1 mg/kg 5 mg/kg 20 mg/kg
SNR antrum 2 [1-3] 4 [3-6] 6 [4-13] 19 [8-37]
SNR duodenal bulb 3 [2-7] 233 [165-533] 702 [179-900] 617 [269-921]
SNR descending duodenum 6 [5-6] 29 [18-56] 215 [156-684] 110 [77-248]
Adverse events 0/1 0/2 0/2 3/5 phototoxicity
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antrum were too low and caused non-physiological lifetimes,
measurements in gastric antrum were not included in the
analysis of the influence of butylscopolamine.
3.4 | Demonstrating oxygen-dependent signal
Raw delayed fluorescence lifetime traces were recorded.
When the probe was “loose” hovering above the GI tissue
short lifetimes were measured. While the pressure was applied
the lifetime increased, shown in the Bulbus in Figure 4.
For the lifetime distribution analysis a base of 15 recipro-
cal lifetimes equally distributed over a corresponding physi-
ological PO2 range (0-150 mm Hg) assuming a quenching
constant of 830 mm Hg−1 and lifetime of spontaneous relax-
ation of 800 μs was taken [1]. The distribution analysis was
done on the 2 times 3 loose and 2 times 3 pressure traces.
The averaged distributions of both the loose and pressure
measurements are shown in Figure 4. While pressure was
applied a fraction of 0.55 of the signal fell in the bin with
central reciprocal lifetime 0.005 μs−1. Such lifetimes around
200 μs and even longer, as in this bin, indicate that a large
part in the measurement volume is ischemic. The decrease in
oxygen resulted in a distribution that has shifted to the left
(lower PO2) compared to the loose situation [3]. To analyze
the heterogeneity between different spots of mucosal tissue,
all “loose” data was combined into a histogram. To visualize
the contribution of individual volunteers the data is color
categorized per subject, shown in Figure 5.
All measurements performed while applying pressure on
the mucosa were significantly lower compared to measure-
ments performed without pressure at all measurements loca-
tions (Table 2). Figure 6 displays a decrease of reciprocal
lifetime when pressure is applied with values decreasing fur-
ther when pressure is maintained for a longer period of time.
The oxygen disappearance curve (Figure 7) supports this find-
ing and shows a decrease of reciprocal lifetime over time,
demonstrating the disappearance of oxygen due to ongoing
oxygen consumption, while temporary ischemia is induced.
3.5 | Determining influence of
butylscopolamine
Delayed fluorescence before and after administration of but-
ylscopolamine did not differ significantly in the duodenal
0
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FIGURE 2 Signal-to-noise ratio (SNR) sorted by oral dose
5-aminolevulinic acid (ALA) combined for all measurement locations
(gastric antrum, duodenal bulb, descending duodenum). Measurements
are performed without pressure applied. Outliers are not presented
since SNRs in 5 and 20 mg/kg go up to 6000
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FIGURE 3 Reciprocal lifetimes 1=τ (with lifetime τ in microseconds) versus signal-to-noise ratio (SNR) of all measurements without pressure
applied specified for each measurement location
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bulb (Figure 8). In the descending duodenum, reciprocal
lifetimes before administration of butylscopolamine
were significantly lower than after administration of
butylscopolamine (Figure 8). Measurements before and after
administration of butylscopolamine did no longer differ sig-
nificantly (P = .281) when the lowest duodenal values
before administration of butylscopolamine are excluded.
These measurements were performed while unintended pres-
sure was applied to the mucosa due to intestinal
contractions.
4 | DISCUSSION
This study showed that delayed fluorescence measurements
of ALA-induced PpIX in the GI tract during upper GI endos-
copy are technically feasible and that the measured signal is
oxygen-dependent. We determined an optimal dose of 5 mg/kg
ALA and duodenal bulb and descending duodenum as suitable
measurement locations. Administration of butylscopolamine
during upper GI endoscopy did not influence the measured GI
delayed fluorescence signal (reciprocal lifetimes).
ALA-induced enhancement of mitochondrial PpIX pro-
vided the first method to measure mitochondrial PO2 in liv-
ing cells [1]. In a time window of some hours after
administration of ALA the PpIX is confined in the mito-
chondria as shown in animal studies in rat liver [18] and rat
heart [19]. Since PpIX diffuses slowly out of the
Location: Bulbus
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FIGURE 4 A, The normalized delayed fluorescence traces recorded in the Bulbus with 5 mg/kg 5-aminolevulinic acid. The traces represent
three loose followed by three measurements while pressure was given with the probe on the tissue to induce local ischemia. This sequence was
repeated for a second time. For the distribution analysis (histograms) a base of 15 reciprocal lifetimes equally distributed over a corresponding
physiological PO2 range (0-150 mm Hg) assuming a quenching constant of 830 mm Hg
−1 and lifetime of spontaneous relaxation of 800 μs was
taken [1]. Histograms show reciprocal lifetime distributions of traces of the first panel. B, and D, Average of three loose measurements. C and E,
Average of three measurements while pressure was applied on the tissue with the optical probe. Histogram data presented as mean ± SEM
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5 and 20 mg/kg 5-aminolevulinic acid (ALA) administration. The
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mitochondria, it will not solely remain in the mitochondria,
making the localization of the signal less specific over time.
The COMET system provides the clinical parameter
“mitoPO2” (mitochondrial oxygen tension), to distinguish
the measurement from, for example, hemoglobin-based “tis-
sue oxygen” measurements, since such parameters provide
other information from different tissue compartments [4].
However, the reader should keep in mind that the origin
of the PpIX delayed fluorescence signal is not only
mitochondrial and depends on tissue type, and the amount of
time after ALA administration.
Administration of ALA is needed for reliable endo-
scopic delayed fluorescence lifetime measurements since
the amount of endogenously present PpIX is not sufficient
for measurements using the current setup. The optimal
dose of ALA is a compromise between sufficient signal
quality and no or few side effects. The signal quality was
high for a dose of 20 mg/kg ALA, however, phototoxicity
was reported in 60%. Measured reciprocal lifetime values
were disproportionally high at a dose of 1 mg/kg ALA
compared to the values measured with 5 or 20 mg/kg
ALA. This finding suggests the occurrence of dispropor-
tional high reciprocal lifetime values at low SNRs due to
insufficient ALA dose. An explanation may be the occur-
rence of PpIX photobleaching, caused by the white xenon
light source of the endoscope plus the potential photo-
bleaching effect of the green laser light. The total amount
of light exposure depends on the endoscopic observation
time. But despite the endoscopic light source, the mea-
surements could be performed with sufficient signal qual-
ity. With technical and medical considerations in mind,
we advise an ALA dose of 5 mg/kg for endoscopic
oxygen-dependent delayed fluorescence measurements,
since we showed reliable delayed fluorescence measure-
ments without any side effects after administration of
this dose.
TABLE 2 Reciprocal lifetime (in units, 1/τ μs−1) of gastrointestinal (GI) tissue PO2 measurements with and without pressure applied for each
measurement location
Location
1/τ loose
median [interquartile range]
1/τ pressure
median [interquartile range] P-value
Antrum 0.092 [0.061-0.132] 0.052 [0.032-0.069] <.001
Duodenal bulb 0.041 [0.032-0.049] 0.013 [0.010-.0.022] <.001
Descending duodenum 0.016 [0.011-0.026] 0.009 [0.008-0.011] <.001
Note: 5-Aminolevulinic acid dose is 5 and 20 mg/kg, total of seven upper GI endoscopies.
p <0.001
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(loose) and three consecutive
measurements during pressure
application (pressure 1, pressure
2, pressure 3). B, Measurements in the
duodenal bulb. The x-axis shows
measurements just above tissue (loose)
and three consecutive measurements
during pressure application (pressure
1, pressure 2, pressure 3)
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duodenal bulb
8 of 11 VAN DIJK ET AL.
The COMET device determines mitoPO2 by the delayed
fluorescence lifetime of PpIX after excitation with a laser
pulse. The measurement has been calibrated for skin and in
that case, reciprocal lifetime is linearly proportional to oxy-
gen tension in mm Hg [1]. The calibration constants in the
human gastro-duodenal tract are unknown, as a conse-
quence, all data is represented in reciprocal lifetimes 1/τ
(μs−1). The measured lifetimes in the gastric antrum were
short, with a median value of 10.8 μs, that would have cor-
responded with non-physiological high PO2 values if the
currently available calibration constants were used [1]. The
reason why the gastric antrum has short delayed fluorescent
lifetimes has not been studied. We consider the histological
composition and function of the mucosa could interfere with
the excitation light of the delayed fluorescent signal itself. It
could be that the ability of these cells to accumulate PpIX is
lower, e.g. due to a relatively slow cellular turnover,
resulting in low SNRs and unreliable short lifetimes.
We determined the influence of administration of but-
ylscopolamine on the endoscopic delayed fluorescence sig-
nal since butylscopolamine is commonly administered
intravenously in clinical practice if intestinal contractions
hamper the endoscopy. Delayed fluorescence lifetimes
before and after administration of butylscopolamine did not
differ significantly in the duodenal bulb, however, in the
descending duodenum, the reciprocal lifetimes before
administration of butylscopolamine were significantly lower
than after administration. These lower values were due to
unintended application of pressure during measurements,
caused by peristaltic movements of the bowels. During the
endoscopic GI delayed fluorescence measurements, the
green light emitted by the laser is visible when the
endoscopic light is switched off. When peristaltic move-
ments of the bowels were present we frequently observed
fading or even disappearance of the green light when the GI
mucosa pressed against the fiber. At the same time, lower
reciprocal lifetime values were noted. Since the endoscopic
light has to be switched off during GI delayed fluorescence
measurements, correcting the position of the probe to avoid
contact with the mucosa is difficult in contractile bowels.
After excluding the low values caused by unintended appli-
cation of pressure, no significant differences in reciprocal
lifetime before and after butylscopolamine remained. There-
fore, we conclude that butylscopolamine does not influence
the endoscopic GI tissue reciprocal lifetime values, however,
when intestinal contractions are present measurements can
be affected by unintended application of pressure. We advise
to administer butylscopolamine during duodenal delayed
fluorescence measurements when intestinal contractions are
present, to increase the reliability of the measurements. Fur-
thermore, future design of the probe with development of
pressure sensors on the probe tip to avoid measurements dur-
ing unintended application of pressure with the probe tip on
the GI mucosa could be a solution for this problem.
This study has some limitations. First, the measured GI
tract delayed fluorescence measurements in this study are
presented as reciprocal lifetime since the calibration con-
stants for the mucosa of the GI tract are unknown yet. Sec-
ond, during the GI tissue measurements, the light of the
endoscope has to be switched off to minimize background
noise. Furthermore, the probe tip currently consists of sharp
edges, which can possibly damage the GI mucosa. Finally,
the amount of endogenous PpIX is far from sufficient to
measure GI delayed fluorescence using COMET. Necessity
to administrate ALA causes a delay between oral intake and
the first measurement opportunity, aside from potential pho-
totoxic effects. Fortunately, we did not register any adverse
events with 5 mg/kg ALA. The use of a commercial device
limited our choice to an excitation wavelength of 515 nm,
since this is the excitation wavelength of the COMET
device, which is designed for cutaneous delayed fluores-
cence measurements after topical application of ALA [4].
This wavelength is a tradeoff between melatonin and hemo-
globin absorption, topical applied ALA penetration depth,
and measurement volume depth. The penetration depth of
green light in the gut is very limited [21], and in our applica-
tion the use of 515 nm excitation light likely limits the mea-
surement depth to the mucosa. However, since ALA is
systemically administered in this application, other excita-
tion wavelengths could provide more efficient photo excita-
tion and improve SNR, or alter the penetration depth and
increase measurement volume.
For the interpretation of the signal in terms of quantitative
oxygen measurements additional research into the
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FIGURE 8 A, measurements with 5 mg/kg 5-aminolevulinic acid
(ALA) in duodenal bulb without butylscopolamine versus
measurements with butylscopolamine and B, measurements with
5 mg/kg ALA in descending duodenum without butylscopolamine
versus measurements with butylscopolamine
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localization of PpIX and the photo-physical properties of the
delayed fluorescence would be very helpful. For example,
Vinklárek et al described a Singlet Oxygen Feedback-
Induced mechanism (SOFDF) that influences the delayed
fluorescence of PpIX under certain non-physiological circum-
stances [22]. It is currently unknown to what extent other
mechanisms than T-type delayed fluorescence, like this
SOFDF mechanism, contribute to the in vivo delayed fluores-
cence signal. Although we are determined to improve our
measurement and eventually hope to be able to convert the
measured lifetimes to PO2 levels this in itself is not necessary
for successful clinical application. The only relevant question
here is whether the measured lifetimes in healthy subjects dif-
fer from patients with, for example, CMI. Sensitivity and
specificity of the technique could equally well be studied and
calculated on reciprocal lifetimes instead of oxygen tensions.
In conclusion, measurement of oxygen-dependent del-
ayed fluorescence of ALA-induced PpIX during upper GI
endoscopy is feasible and safe. Further research is needed
for the clinical applicability of this technique in the diagnos-
tic work-up of CMI, starting with endoscopic GI delayed
fluorescence measurements in patients suspected of CMI to
determine its discriminative ability and to determine cut-off
values for the inverse lifetime measurements for mucosal
ischemia. Further research has to determine whether a more
accurate diagnosis of CMI can be established when the pres-
ence of mucosal ischemia detected by endoscopic delayed
fluorescence measurements is combined with the symptoms
and imaging of the mesenteric arteries, and ultimately
whether its use results in less patients treated for suspected
CMI (with the associated risks and costs of revascularization
therapy) who will not experience relief of symptoms since
they are false positively diagnosed by current standards.
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